Where AI Actually Changes the Economics of Telehealth

in #ai • 14 days ago

Follow the money through a single virtual appointment, and you will see that much of the cost does not sit in the appointment. Someone collects history beforehand. Someone sorts out the schedule. A clinician conducts the visit, then writes it up and handles the messages that follow. First-generation telehealth moved the middle of that sequence onto a screen and left the rest largely untouched. This overview looks at each stage to ask where AI can plausibly shift the cost, and where the claims run ahead of reality.

Senior physician at his desk meeting with a patient remotely through a laptop

Before the visit: reducing preparation work

Costs at this stage are easy to overlook, since they are spread across coordinators, nurses and the first few minutes of each consultation.

Where AI may help:

  • Intake summaries. Patient answers, prior notes and recent results can be condensed into a short briefing for the clinician, who then starts the conversation already oriented.
  • Routing support. Language models can help sort requests and suggest a suitable queue, with licensure and coverage checks still handled by explicit rules.
  • Demand and no-show forecasting. Clinician schedules are often the largest controllable cost in a virtual clinic, so even modest improvements in staffing against demand could matter.

What to watch: A summary that leaves out a crucial detail costs more than it saves. Clinicians need an easy path to the original information, and the summary needs regular checks against its sources.

During the visit: the smallest direct change

This stage is where AI is most talked about and, paradoxically, where the direct effect on cost may be smallest. Licensed clinicians must exercise their judgment, and that time cannot simply be compressed away.

The gain is indirect. If a clinician is not typing while talking, attention returns to the patient. If the briefing was good, less time goes to re-asking basic questions.

A caution belongs here too. Software that interprets images, flags a diagnosis or directs treatment beyond what a clinician can independently review may count as a medical device under FDA oversight. That is a far more expensive path, so organizations should know which side of the line a feature falls on before designing it. Discuss the specifics with healthcare counsel.

After the visit: the most mature opportunity

Charting and follow-up are where the case tends to be strongest.

  • Ambient documentation. A draft note built from the conversation is the best-established use case, and it addresses after-hours charting, a recognized contributor to burnout. Telehealth has a technical advantage here, because the audio is already digital and speakers can often be separated by channel.
  • Message drafting. Patient messages can grow after a virtual program launches. Drafting replies for clinician approval, and flagging those that look urgent, can ease that load.
  • Administrative tasks. Prior authorization chasing, follow-up reminders and record updates are candidates for AI agents, which take actions rather than merely making suggestions. Permissions, approvals and rollback then become as important as accuracy. TechCirkle's overview of agentic workflow development discusses those patterns.

One limit deserves emphasis: a draft that must be copied by hand into the record loses much of its value. Integration quality, rather than model quality, is often the constraint on these savings. Budgets may do more good on EHR write-back than on trying another model.

Phone, stethoscope and open notepad grouped on a blue background

Asynchronous care: where the model itself can shift

The three stages above assume that a live visit stays at the center. Asynchronous care questions that assumption.

For well-defined, lower-acuity conditions, a patient can complete a structured intake, and a clinician can review it and respond later. No scheduled video call takes place. AI can assemble the case and draft a response, while the clinician retains the decision.

Economically, this differs from making a visit slightly more efficient. It changes how many cases one clinician can safely manage, removes much of the no-show problem, and frees the live video slot for the cases that truly need it. In this model the video call is an expensive escalation step within a mostly asynchronous pathway.

The conditions matter greatly, however:

  • State rules and payer coverage differ, and some pathways may not be permitted or reimbursed. Confirm with healthcare counsel and payers.
  • Conditions need clear criteria and a dependable route to escalate anything unusual.
  • Certain generative AI clinical communications carry disclosure requirements, including under California's AB 3030.

The costs AI adds

Any fair ledger has two sides. AI brings new line items, and these should appear in the business case:

  • Usage fees for models and transcription, which scale with volume
  • Evaluation work, such as sampling notes against audio and tracking error types
  • Clinician review time, which is reduced but does not vanish
  • Vendor agreements, since a business associate agreement should cover each service that touches patient data, including model and transcription providers
  • Governance, including data retention decisions, audit logs, and bias testing across languages and accents
  • Fallback operations, because the clinic needs to keep running when a model is down

How to measure the change

Visit volume can make a program look healthier than it is. These measures give a better view of whether AI is truly changing the economics:

  • Net revenue per clinician hour
  • After-hours charting time
  • Time from request to care
  • Follow-up completion
  • Share of eligible cases safely handled asynchronously
  • Error and safety events, which should sit next to every efficiency metric

Keep the bar for widening automation high: administrative action can come first, while clinical judgment stays with clinicians.

In summary

AI does not make the video call much cheaper. Its bigger effect lies in shrinking the work around the call and, for suitable conditions, removing the need for a scheduled call at all. That only pays off when systems are well connected, evaluation is taken seriously, and regulatory limits are respected.

For a broader treatment of scope, regulation and planning-level costs, see this guide to telehealth app development services. Teams thinking about where AI fits their product can also review TechCirkle's AI development services.

Frequently Asked Questions

Which part of a telehealth visit benefits most from AI?

Work after the visit is typically the most mature area, especially draft notes and message support. Pre-visit summaries are also promising. The live consultation changes less directly, because clinical judgment remains with the clinician.

What is asynchronous telehealth?

It is care delivered without a live call. A patient submits structured information, and a clinician reviews it and responds later. It suits certain well-defined, lower-acuity conditions, subject to state rules and payer coverage.

Does AI lower the cost of running a virtual clinic?

It can reduce specific kinds of work, but it also adds usage fees, evaluation, governance and review time. Whether the net result is positive depends on your setting, so a measured pilot is more reliable than a general estimate.

Why does EHR integration affect AI savings?

If a clinician has to copy a draft note into the chart by hand, a large part of the time saved is lost. Reliable write-back lets AI output fit into the existing workflow, which is where much of the benefit comes from.

Can AI handle asynchronous cases without a clinician?

Treat that as outside normal scope. AI can gather information and draft responses, but a licensed clinician should make the decision. Autonomous direction of diagnosis or treatment may also raise medical device questions under FDA oversight.

Sort:  

Lo de los no-show forecasting me parece clave, porque como decís la agenda del clínico es el costo más grande y ahí sí la diferencia se nota. ¿Viste algún caso real donde bajar los no-shows haya movido la aguja de verdad o sigue siendo teoría?